TP53 and prostate cancer: The known cancer mechanism-related pathways are significantly enriched, such as pathways in cancer, Prostate cancer, miRNAs in cancer, Pancreatic cancer, Chronic myeloid leukemia, Melanoma, the p53 signaling pathway, small cell lung cancer, colorectal cancer, acute myeloid leukemia, Transcriptional misregulation in cancer, Glioma and Non-small cell lung cancer.